SCHEMBL812054

SCHEMBL812054

O=C(O)NC1COCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9990084 0.90
SCHEMBL1865543 0.78 ATM (0.42)
SCHEMBL4321186 0.76
SCHEMBL185632 0.76
SCHEMBL15614617 0.76
Hydrochloric Acid SCHEMBL4325316 0.75 RAB9A (0.40)
SCHEMBL25278363 0.73 EPHX2 (0.31)
SCHEMBL15914451 0.73 EPHX2 (0.31)
SCHEMBL14737868 0.73 EPHX2 (0.31)
SCHEMBL3409533 0.73 NAMPT (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665724-A1 TYPE II TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF Ohio State Innovation Foundation (US) 2025-12-24 EP disclosed
WO-2024173781-A1 TYPE II TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2024-08-22 WO disclosed
CN-102186845-B S1P receptor modulators and their purposes 阿卡制药有限公司 2016-09-07 CN disclosed
EP-2344446-A1 S1P RECEPTORS MODULATORS Akaal Pharma Pty Ltd (AU) 2011-07-20 EP disclosed
WO-2010042998-A1 S1P RECEPTORS MODULATORS AKAAL PHARMA PTY LTD (AU) 2010-04-22 WO disclosed